AzTrials
AzTrials

Healthy AdultNCT07447310

Comparing 360-degree VR Video of Local vs Overseas Environment on Psychological Health

A study testing Local Environment 360-degree VR Video and Overseas Environment 360-Degree VR Video in people with Healthy Adult and Volunteer, run by Universiti Kebangsaan Malaysia Medical Centre at 1 site in Malaysia.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Medical students frequently experience high levels of stress, anxiety, and depression due to intense academic pressures. While spending time outdoors in nature is a proven way to reduce these negative feelings, students rarely have the time to do so. Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
What is being tested?
Local Environment 360-degree VR Video and Overseas Environment 360-Degree VR Video
Could I receive a placebo?
No, everyone receives an active treatment
How many people
82 participants
Where
1 siteMalaysia
Study dates
15 Nov 2024to 31 Aug 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Academic Status: Actively enrolled as a fourth-year or fifth-year undergraduate medical student at Universiti Kebangsaan Malaysia (UKM).
  • Age: 18 years of age or older (necessary for providing legal informed consent).
  • Sensory Ability: Normal or corrected-to-normal vision and hearing (the participant can wear contact lenses or glasses that comfortably fit inside the VR headset).
  • Availability: Willing and able to commit to the full 2-week study timeline, including both the baseline and follow-up VR sessions.

Who cannot join

  • VR Safety (Neurological): Personal history of epilepsy, seizure disorders, or frequent migraines, as VR screens can occasionally trigger these conditions.
  • VR Safety (Vestibular): History of severe motion sickness, vertigo, or inner ear disorders.
  • Confounding Medical Factors: Currently receiving active, formal psychiatric treatment or taking prescribed psychoactive medications (such as antidepressants or anxiolytics).
  • Physical Limitations: Severe visual or auditory impairments that would prevent full immersion in the visual and auditory elements of the VR environment.

Trial locations and contacts

1 site in 1 country.

Malaysia1 site
  • Psychiatry Department, Hospital Canselor Tuanku Muhriz UKM

    Cheras, Selangor, 56000

Other trials in Malaysia

About this study

Official title: The Use Of 360-Degree VR Video For The Psychological Health Of Medical Students: Comparison Of Effectiveness Between Local And Overseas Environments

Medical students frequently experience high levels of stress, anxiety, and depression due to intense academic pressures. While spending time outdoors in nature is a proven way to reduce these negative feelings, students rarely have the time to do so. This study aims to find out if using a 360-degree Virtual Reality (VR) headset to experience immersive nature environments can provide similar relaxing benefits.

The main question this study attempts to answer is whether the type of nature environment matters: Does watching a familiar, local Malaysian nature scene reduce stress more or less effectively than watching a novel, overseas nature scene?

The researchers hypothesize that a brief, 15-minute exposure to either 360-degree VR nature environment will successfully reduce short-term feelings of stress, anxiety, and depression. Furthermore, they hypothesize that there will be a measurable difference in the psychological benefits between the local and overseas environments, driven by either the comfort of familiarity (local) or the distraction of escapism (overseas).

Read the detailed description

Background and Rationale:

Accessible, non-pharmacological interventions are increasingly necessary to support the mental wellness of university cohorts facing high academic strain. While the restorative effects of natural environments on human psychology are well-documented, physical access to such spaces is often limited in urban academic settings. 360-degree Virtual Reality (VR) offers a highly immersive, scalable alternative. By simulating spatial presence, VR can trigger physiological and psychological relaxation responses similar to actual nature exposure. However, a gap remains in the literature regarding the semantic content of the VR exposure. Specifically, it is unclear whether the therapeutic efficacy of VR nature exposure is heavily influenced by environmental familiarity (which may foster psychological safety and place attachment) versus environmental novelty (which may promote greater cognitive distraction and escapism).

Study Design and Randomization:

This protocol utilizes a randomized, parallel-group behavioral trial design. To ensure group equivalence and minimize gender as a potential confounding variable in psychological stress reporting, a custom-developed Python script will be utilized to execute stratified randomization. This algorithm ensures a strict 1:1 allocation ratio into either the active local environment arm or the active overseas environment arm, while maintaining a perfectly balanced male-to-female ratio within each experimental group.

Intervention Delivery and Statistical Plan:

Participants undergo a structured behavioral intervention consisting of immersive 360-degree VR video viewing via a head-mounted display. The protocol requires two identical exposure sessions, separated by a strict two-week interval to evaluate repeated-dose efficacy and short-term trajectory. All self-reported psychological and well-being metrics are collected at baseline, immediately post-initial exposure, and immediately post-secondary exposure. Data will be evaluated utilizing a repeated-measures analysis of variance (ANOVA). This statistical approach is specifically chosen to assess two primary effects: the main effect of time (evaluating the overall impact of the VR intervention across all participants throughout the two-week study period) and the interaction effect of time and group (determining if there is a statistically significant divergence in the trajectory of symptom reduction between the local and overseas experimental arms).

Being tested
Local Environment 360-degree VR Video, Overseas Environment 360-Degree VR Video
Keywords
virtual reality, anxiety, general well-being, depression, 360-degree video
Medical subject headings
Stress, Psychological, Anxiety Disorders, Depression

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Local Environment 360-degree VR VideoBehavioural

    Also called Malaysian Environment

    Participants undergo a 15-minute viewing of a 360-degree local environment video via a VR headset. This session is repeated once, exactly two weeks after the initial session.

  • Overseas Environment 360-Degree VR VideoBehavioural

    Also called Western European Environment

    Participants undergo a 15-minute viewing of a 360-degree overseas environment video via a VR headset. This session is repeated once, exactly two weeks after the initial session.

Study groups in NCT07447310
Study groupRoleWhat they receive
Local VR GroupExperimentalParticipants assigned to this group will exclusively view the local 360-degree VR environment.
Receives: Behavioral: Local Environment 360-degree VR Video
Overseas VR GroupActive comparatorParticipants assigned to this group will exclusively view the overseas 360-degree VR environment.
Receives: Behavioral: Overseas Environment 360-Degree VR Video

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in Depression, Anxiety, and Stress Severity (DASS-21)

    Evaluated using the Depression, Anxiety and Stress Scale-21 Items (DASS-21). This 21-item self-report questionnaire measures the core symptoms of depression, anxiety, and stress across three 7-item subscales. Items are rated on a 4-point Likert scale. Raw subscale scores are summed and multiplied by two to calculate final subscale scores. Higher scores indicate a greater severity of negative emotional symptoms.

    Measured: Baseline (T0 - immediately before the first 15-minute intervention), Day 0 (T1 - immediately after the first intervention), and Week 2 (T2 - immediately after the second intervention).

Secondary outcomes (1)
  1. Change in Subjective Psychological Well-Being (WHO-5)

    Evaluated using the WHO-5 Well-Being Index. This 5-item self-report questionnaire measures subjective psychological well-being. Items are rated on a 6-point scale from 0 ("At no time") to 5 ("All of the time"). The raw score (ranging from 0 to 25) is multiplied by 4 to convert it to a percentage scale from 0 to 100. Higher scores reflect better subjective well-being.

    Measured: Baseline (T0 - immediately before the first 15-minute intervention), Day 0 (T1 - immediately after the first intervention), and Week 2 (T2 - immediately after the second intervention).

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted3 Mar 2026
  2. Study start15 Nov 2024
  3. Primary completion1 Jul 2025
  4. Study completion31 Aug 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Model description
The participants are randomly divided into two groups using Python randomization script. Group A will only experience the local environment while Group B will only experience the overseas environment.
Masking
Single blind
Who is masked
Investigator
Enrolment
82 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07447310
Sponsor's protocol ID
JEP-2024-039
Status last verified
Feb 2026
First submitted
25 Feb 2026
Last updated
3 Mar 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Annerstedt M, Jonsson P, Wallergard M, Johansson G, Karlson B, Grahn P, Hansen AM, Wahrborg P. Inducing physiological stress recovery with sounds of nature in a virtual reality forest--results from a pilot study. Physiol Behav. 2013 Jun 13;118:240-50. doi: 10.1016/j.physbeh.2013.05.023. Epub 2013 May 18.

    PubMed 23688947
  • Martin JL, Saredakis D, Hutchinson AD, Crawford GB, Loetscher T. Virtual Reality in Palliative Care: A Systematic Review. Healthcare (Basel). 2022 Jun 29;10(7):1222. doi: 10.3390/healthcare10071222.

    PubMed 35885749
  • Quek TT, Tam WW, Tran BX, Zhang M, Zhang Z, Ho CS, Ho RC. The Global Prevalence of Anxiety Among Medical Students: A Meta-Analysis. Int J Environ Res Public Health. 2019 Jul 31;16(15):2735. doi: 10.3390/ijerph16152735.

    PubMed 31370266
  • Tanja-Dijkstra K, Pahl S, White MP, Auvray M, Stone RJ, Andrade J, May J, Mills I, Moles DR. The Soothing Sea: A Virtual Coastal Walk Can Reduce Experienced and Recollected Pain. Environ Behav. 2018 Jul;50(6):599-625. doi: 10.1177/0013916517710077. Epub 2017 Jun 14.

    PubMed 29899576
  • White MP, Alcock I, Grellier J, Wheeler BW, Hartig T, Warber SL, Bone A, Depledge MH, Fleming LE. Spending at least 120 minutes a week in nature is associated with good health and wellbeing. Sci Rep. 2019 Jun 13;9(1):7730. doi: 10.1038/s41598-019-44097-3.

    PubMed 31197192
  • Anderson AP, Mayer MD, Fellows AM, Cowan DR, Hegel MT, Buckey JC. Relaxation with Immersive Natural Scenes Presented Using Virtual Reality. Aerosp Med Hum Perform. 2017 Jun 1;88(6):520-526. doi: 10.3357/AMHP.4747.2017.

    PubMed 28539139
  • Iqbal S, Gupta S, Venkatarao E. Stress, anxiety and depression among medical undergraduate students and their socio-demographic correlates. Indian J Med Res. 2015 Mar;141(3):354-7. doi: 10.4103/0971-5916.156571.

    PubMed 25963497
  • Dahlin M, Joneborg N, Runeson B. Stress and depression among medical students: a cross-sectional study. Med Educ. 2005 Jun;39(6):594-604. doi: 10.1111/j.1365-2929.2005.02176.x.

    PubMed 15910436
  • Hatta MHB, Abdul Samad FD, Chong SK, Mohamed Saini S. The Efficacy of Local Versus Overseas Natural Environments in 360-Degree Virtual Reality Video for Improving Mental Wellness in Medical Students: A Retrospectively Registered Two-Arm Parallel Randomized Trial. Healthcare (Basel). 2026 Apr 20;14(8):1087. doi: 10.3390/healthcare14081087.

    PubMed 42072987

Questions about this trial

What is this clinical trial studying?

A study testing Local Environment 360-degree VR Video and Overseas Environment 360-Degree VR Video in people with Healthy Adult and Volunteer, run by Universiti Kebangsaan Malaysia Medical Centre at 1 site in Malaysia.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 3 Mar 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Malaysia. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in Depression, Anxiety, and Stress Severity (DASS-21) (time frame: Baseline (T0 - immediately before the first 15-minute intervention), Day 0 (T1 - immediately after the first intervention), and Week 2 (T2 - immediately after the second intervention).). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07447310, which also lists 9 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 Mar 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in